Pharmaceutical News

RSS

Oral Nirmatrelvir's effects on long COVID symptoms

In a recent study posted to the Research Square* preprint server, researchers at the University of California, San Francisco, examined the cases of three individuals who received nirmatrelvir/ritonavir antiviral therapy at different stages following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

4 May 2022

New drug combinations for obesity and diabetes may show greater efficacy than single therapy

Canadian and German researchers are teaming up to identify new drug combinations to treat people with obesity and Type 2 diabetes.

4 May 2022

Injectable hydrogels for single-dose COVID-19 vaccination

Several coronavirus disease 2019 (COVID-19) vaccines require multiple doses for long-lasting immunity. However, a new study published in the journal Biomacromolecules has developed a promising single-dose vaccine platform using an injectable hydrogel containing an epitope-labeled plant virus, Cowpea mosaic virus (CPMV).

4 May 2022

Medicare surprise: Drug plan prices touted during open enrollment can rise within a month

Something strange happened between the time Linda Griffith signed up for a new Medicare prescription drug plan during last fall's enrollment period and when she tried to fill her first prescription in January.

3 May 2022

Prior SARS-CoV-2 infection provides substantial and sustained protection from Omicron hospitalization

A population-level study conducted on residents of the Quebec province, Canada, has demonstrated that prior infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces robust and long-lasting protection against omicron re-infection and hospitalization. The level of protection further increases with coronavirus disease 2019 (COVID-19) vaccination.

3 May 2022

$Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?$

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

A recent research paper posted to the Research Square* preprint server assessed the dose fractionation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.

1 May 2022

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

A recent research paper posted to the bioRxiv* preprint server demonstrated that a cocktail of two synergetic antibodies extensively neutralized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, including Omicron BA.1 and BA.2.

1 May 2022

At US hospitals, a drug mix-up is just a few keystrokes away

More than four years ago, Tennessee nurse RaDonda Vaught typed two letters into a hospital's computerized medication cabinet, selected the wrong drug from the search results, and gave a patient a fatal dose.

29 Apr 2022

Emergency contraception marks a new battle line in Texas

"Mysterious Dolphin" needed an emergency contraception pill dropped off on a porch outside of town.

28 Apr 2022

Nearly 60% of Americans infected by Omicron

A recent study published in the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-induced viral antibodies (Abs) seroprevalence in the United States (US).

28 Apr 2022

Does re-freezing COVID-19 mRNA vaccines affect immunogenicity?

A new study published in the journal Vaccines evaluated if re-freezing coronavirus disease 2019 (COVID-19) mRNA vaccine vials preserved the immunogenicity.

27 Apr 2022

Research highlights importance of booster vaccine doses to protect against all Omicron variants

In a recent study published in the Cell Host and Microbe journal, researchers examined the neutralization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1, BA.1.1, and BA.2 sublineages.

27 Apr 2022

Fourth dose of COVID vaccine in over 60 years significantly effective

In a recent study published in the Nature Medicine journal, the researchers assessed the effectiveness of a second booster dose of the BioNTech, Pfizer BNT162b2 vaccine against coronavirus disease 2019 (COVID-19) severity in elderly patients.

26 Apr 2022

Well-established group of antimalarials unlikely to be affected by resistance, study shows

New research published today in Antimicrobial Agents and Chemotherapy, shows that the well-established group of antimalarials, known as artemisinins, are unlikely to be affected by resistance.

26 Apr 2022

New drug combo emerges as a potential candidate for oral pericoital contraception

A new combination of drugs has emerged as a "promising candidate" for an on-demand contraceptive pill, suggests preliminary research published online in the journal BMJ Sexual & Reproductive Health.

26 Apr 2022

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

In a recent study published in the Journal of Hepatology, researchers reported that the coronavirus disease 2019 (COVID-19) vaccination could elicit a distinct T cell-dominant immune-mediated hepatitis.

25 Apr 2022

Monoclonal-antibody combination AZD7442 prevents COVID-19

In a recent study published in The New England Journal of Medicine, the researchers examined the monoclonal-antibody combination AZD7442 to prevent coronavirus disease 2019 (COVID-19).

25 Apr 2022

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Researchers investigate the duration of effectiveness of mRNA-based COVID-19 vaccines in preventing ICU admission.

21 Apr 2022

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

A new study published in PLoS ONE characterizes the antibody response to BNT162b2, the Pfizer-BioNTech COVID-19 vaccine

20 Apr 2022

Radioconjugates could transform the future of cancer care

Many current cancer treatments make patients very sick because even the most targeted treatments kill healthy cells as well as cancer cells. But a new type of treatment called a radioconjugate is getting the attention of oncologists.

20 Apr 2022

Pharmaceutical News

Oral Nirmatrelvir's effects on long COVID symptoms

New drug combinations for obesity and diabetes may show greater efficacy than single therapy

Injectable hydrogels for single-dose COVID-19 vaccination

Medicare surprise: Drug plan prices touted during open enrollment can rise within a month

Prior SARS-CoV-2 infection provides substantial and sustained protection from Omicron hospitalization

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

At US hospitals, a drug mix-up is just a few keystrokes away

Emergency contraception marks a new battle line in Texas

Nearly 60% of Americans infected by Omicron

Does re-freezing COVID-19 mRNA vaccines affect immunogenicity?

Research highlights importance of booster vaccine doses to protect against all Omicron variants

Fourth dose of COVID vaccine in over 60 years significantly effective

Well-established group of antimalarials unlikely to be affected by resistance, study shows

New drug combo emerges as a potential candidate for oral pericoital contraception

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

Monoclonal-antibody combination AZD7442 prevents COVID-19

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Radioconjugates could transform the future of cancer care

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News